NEW YORK (GenomeWeb News) – Imperial College London has installed Syngene’s gel-imaging system at its Institute of Biomedical Engineering to identify proteins linked with various human diseases, Syngene said this week.
Syngene, based in Cambridge, UK, said the Institute will use the Dyversity 2D system in a “wide array” of research tasks, including imaging 1D protein and DNA gels, and chemiluminescent blots stained with visible, fluorescent, and chemiluminescent dyes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.